Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Current Drug Target -Inflammation & Allergy
2004English

Role of Chemokine Receptors in Thyroid Cancer and Immunotherapy

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Chemokine Receptors as Therapeutic Targets

Japanese Journal of Clinical Immunology
2013English

Chemokines in the Cancer Microenvironment and Their Relevance in Cancer Immunotherapy

Nature Reviews Immunology
MedicineAllergyImmunology
2017English

New Emerging Targets in Cancer Immunotherapy: The Role of Neoantigens

ESMO Open
Cancer ResearchOncology
2020English

Chemokines and Chemokine Receptors Expression in the Lesions of Patients With American Cutaneous Leishmaniasis

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2013English

New Tricks for Old Targets: Anti-Ctla-4 Antibodies Re-Envisioned for Cancer Immunotherapy

Oncotarget
Oncology
2018English

Implications of Chemokine Receptors and Inflammatory Lipids in Cancer

ImmunoTargets and Therapy
AllergyImmunology
2013English

Expression of Specific Chemokines and Chemokine Receptors in the Central Nervous System of Multiple Sclerosis Patients

Journal of Clinical Investigation
Medicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy